ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BRKRP vs UNH // FORWARD P/E MULTIPLE

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BRKRP 2 — UNH 13
▲ FORWARD P/E MULTIPLE LEADER: UNH
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BRKRP VS. UNH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BRKRP UNH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 45.90% 88.57% -42.67 UNH /gross-margins <GO>
Return on Invested Capital (ROIC) 1.00% 11.47% -10.47 UNH /roic <GO>
EV/EBITDA & P/E Valuation 95.0x 16.4x +78.55 UNH /valuation <GO>
Free Cash Flow Yield 0.06% 6.48% -6.42 UNH /fcf-yield <GO>
Operating Margin 2.00% 4.82% -2.82 UNH /operating-margins <GO>
Net Profit Margin -0.20% 3.14% -3.34 UNH /net-margins <GO>
Revenue Growth (YoY) 2.10% 6.46% -4.36 UNH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.03% 2.28% -2.25 UNH /dividend-safety <GO>
Altman Z-Score & Debt/Equity 12.42 3.12 +9.30 BRKRP /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 UNH /piotroski-score <GO>
Options Implied Move & Put/Call Skew 7.30% 6.74% +0.56 UNH /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.7 56.0 -10.37 UNH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.13 0.33 +0.80 BRKRP /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE 23.0x 17.1x +5.91 UNH /forward-pe <GO>
Enterprise Scale & Market Cap $69.20B $364.66B -$295.46B UNH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BRKRP REV UNH REV BRKRP GROSS % UNH GROSS % BRKRP FCF UNH FCF
FY 2025 $3.44B $447.57B 45.9% 88.7% $43.3M $16.07B
FY 2024 $3.37B $400.28B 49.0% 88.3% $136.0M $20.70B
FY 2023 $2.96B $371.62B 44.0% 89.6% $216.7M $25.68B
FY 2022 — $324.16B — 89.6% — $23.40B
FY 2021 — $287.60B — 89.2% — $19.89B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BRKRP // BETA 1.13
UNH // BETA 0.33